Granahan Investment Management’s Soleno Therapeutics SLNO Stock Holding History

Granahan Investment Management’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-114,825	Closed	-$3.84M	–	163
2026 Q1	$3.84M	Sell	114,825 -22,767	-17%	-$893K	0.19%	118
2025 Q4	$6.37M	Buy	137,592 +28,339	+26%	+$1.55M	0.27%	88
2025 Q3	$7.39M	Buy	109,253 +49,276	+82%	+$3.65M	0.3%	74
2025 Q2	$5.02M	Buy	59,977 +27,486	+85%	+$2.06M	0.2%	101
2025 Q1	$2.32M	Buy	+32,491	New	+$1.58M	0.12%	131

Granahan Investment Management's SLNO Position: Q2 2026 in Review

Granahan Investment Management sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 114,825 shares — an estimated $3.84M sold.

Granahan Investment Management first reported a position in SLNO in Q1 2025 and held it in 5 quarters. The position peaked at $7.39M in Q3 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Granahan Investment Management reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Granahan Investment Management sold 114,825 Soleno Therapeutics shares in Q2 2026, an estimated $3.84M.
Granahan Investment Management first reported a position in Soleno Therapeutics in Q1 2025 and held it in 5 quarters.
Granahan Investment Management's Soleno Therapeutics position peaked at $7.39M in Q3 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Granahan Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.